Cicenas Saulius, Vencevicius Vladislavas
Department of Thoracic Surgery and Oncology, Institute of Oncology, Vilnius University, Santariskiu 1, Vilnius, Lithuania.
World J Surg Oncol. 2007 Feb 19;5:22. doi: 10.1186/1477-7819-5-22.
Coexistent lung cancer and pulmonary tuberculosis is an urgent problem of thoracic surgery presenting a challenging task for diagnosis and surgical treatment.
From 1990 to 2005, 2218 patients with lung cancer underwent surgical treatment in Department of Thoracic Surgery and Oncology, Institute of Oncology, Vilnius University. In 46 (2.1%) patients coexistence of lung cancer and tuberculosis was found. Central lung cancer was diagnosed in 37 (80.4%) and peripheral--in 9 (19.6%) patients. Epidermoid cancer was diagnosed in 24 (52.2%) patients, adenocarcinoma--in 10 (21.7%) and adenoepidermoid carcinoma--in 12 (26.1%) patients. Stage I cancer was diagnosed in 12 (26.1%), stage II--in 11 (23.9%), and stage IIIA--in 23 (50%) patients.
Pneumonectomy was performed in 18 (39.2%), lobectomy in 10 (21.7%), bilobectomy in 10 (21.7%), segmentectomy in 8 (17.4%) patients. Postoperative surgical complications were observed in 9 (19.5%) patients, non-surgical complications occurred in 19 patients (41.3%). Six patients (13.04%) died. Combined treatment was applied to 23 (50%) patients.
Coexistence of tuberculosis and lung cancer in thoracic surgery is fairly rare. This combination was diagnosed only in 46 cases (2.1%) out of 2218 operated lung cancer patients. Epidermoid carcinoma and stage IIIA disease was diagnosed in 50% of patients. Postoperative surgical complications occurred in 9 patients (19.5%) with lung cancer and tuberculosis. Six patients (13%) died in postoperative period. Surgery is the method of choice in treatment of combination of tuberculosis and lung cancer. Median survival of these patients was 28 +/- 2 months.
肺癌与肺结核并存是胸外科的一个紧迫问题,给诊断和外科治疗带来了具有挑战性的任务。
1990年至2005年,维尔纽斯大学肿瘤研究所胸外科和肿瘤科对2218例肺癌患者进行了外科治疗。发现46例(2.1%)患者肺癌与肺结核并存。37例(80.4%)诊断为中央型肺癌,9例(19.6%)为周围型肺癌。24例(52.2%)患者诊断为鳞状细胞癌,10例(21.7%)为腺癌,12例(26.1%)为腺鳞癌。12例(26.1%)诊断为Ⅰ期癌症,11例(23.9%)为Ⅱ期,23例(50%)为ⅢA期。
18例(39.2%)患者行全肺切除术,10例(21.7%)行肺叶切除术,10例(21.7%)行双叶切除术,8例(17.4%)行肺段切除术。9例(19.5%)患者出现术后手术并发症,19例(41.3%)出现非手术并发症。6例(13.04%)患者死亡。23例(50%)患者采用联合治疗。
胸外科中肺结核与肺癌并存相当罕见。在2218例接受手术的肺癌患者中,仅46例(2.1%)诊断为此种合并情况。50%的患者诊断为鳞状细胞癌和ⅢA期疾病。9例肺癌合并肺结核患者出现术后手术并发症。6例(13%)患者术后死亡。手术是治疗肺结核与肺癌合并症的首选方法。这些患者的中位生存期为28±2个月。